These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31218973)

  • 21. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial.
    Lago P; Bettiol T; Salvadori S; Pitassi I; Vianello A; Chiandetti L; Saia OS
    Eur J Pediatr; 2002 Apr; 161(4):202-7. PubMed ID: 12014386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative tolerability of pharmacological treatments for patent ductus arteriosus.
    Hammerman C; Kaplan M
    Drug Saf; 2001; 24(7):537-51. PubMed ID: 11444725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeated courses of ibuprofen are effective in closure of a patent ductus arteriosus.
    van der Lugt NM; Lopriore E; Bökenkamp R; Smits-Wintjens VE; Steggerda SJ; Walther FJ
    Eur J Pediatr; 2012 Nov; 171(11):1673-7. PubMed ID: 22864766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patent ductus arteriosus in preterm infants born before 30 weeks' gestation: high rate of spontaneous closure after hospital discharge.
    Romagnoli V; Pedini A; Santoni M; Scutti G; Colaneri M; Pozzi M; Cogo PE; Carnielli VP
    Cardiol Young; 2018 Aug; 28(8):995-1000. PubMed ID: 29954463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patent ductus arteriosus in preterm neonates.
    Aggarwal R; Bajpai A; Deorari AK; Paul VK
    Indian J Pediatr; 2001 Oct; 68(10):981-4. PubMed ID: 11758138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of oral ibuprofen and indomethacin on closure of patent ductus arteriosus in preterm infants.
    Pourarian Sh; Pishva N; Madani A; Rastegari M
    East Mediterr Health J; 2008; 14(2):360-5. PubMed ID: 18561728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ibuprofen--a new application for pharmacological closure of patent ductus arteriosus in preterm infants. Preliminary report].
    Adamska E
    Med Wieku Rozwoj; 2000; 4(2 Suppl 3):65-71. PubMed ID: 11328971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Shah SS; Ohlsson A
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004213. PubMed ID: 16437478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of genetic predisposition to patent ductus arteriosus in preterm infants.
    Dagle JM; Lepp NT; Cooper ME; Schaa KL; Kelsey KJ; Orr KL; Caprau D; Zimmerman CR; Steffen KM; Johnson KJ; Marazita ML; Murray JC
    Pediatrics; 2009 Apr; 123(4):1116-23. PubMed ID: 19336370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.
    Su PH; Chen JY; Su CM; Huang TC; Lee HS
    Pediatr Int; 2003 Dec; 45(6):665-70. PubMed ID: 14651538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ibubrofen in the treatment of patent ductus arteriosus in preterm infants: what we know, what we still do not know.
    Mercanti I; Ligi I; Boubred F; Grandvuillemin I; Buffat C; Fayol L; Millet V; Simeoni U
    Curr Pharm Des; 2012; 18(21):3007-18. PubMed ID: 22564295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indomethacin dosing strategy and neonatal patent ductus arteriosus closure.
    Rathi P; Messina C; Mintzer JP
    J Neonatal Perinatal Med; 2019; 12(4):411-417. PubMed ID: 31561393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ibuprofen lysinate and sodium ibuprofen for prophylaxis of patent ductus arteriosus in preterm neonates.
    De Carolis MP; Bersani I; De Rosa G; Cota F; Romagnoli C
    Indian Pediatr; 2012 Jan; 49(1):47-9. PubMed ID: 21992864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Shah SS; Ohlsson A
    Cochrane Database Syst Rev; 2003; (2):CD004213. PubMed ID: 12804505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baseline cardiac output and its alterations during ibuprofen treatment for patent ductus arteriosus in preterm infants.
    Hsu KH; Wu TW; Wu IH; Lai MY; Hsu SY; Huang HW; Mok TY; Lee CC; Lien R
    BMC Pediatr; 2019 Jun; 19(1):179. PubMed ID: 31167645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of ibuprofen versus indomethacin for the treatment of patent ductus arteriosus in the preterm infant: reviewing the evidence.
    Donze A; Smith JR; Bryowsky K
    Neonatal Netw; 2007; 26(3):187-95. PubMed ID: 17521065
    [No Abstract]   [Full Text] [Related]  

  • 37. Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants.
    Adrouche-Amrani L; Green RS; Gluck KM; Lin J
    BMC Pediatr; 2012 Jan; 12():10. PubMed ID: 22284694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indomethacin for symptomatic patent ductus arteriosus in preterm infants.
    Evans P; O'Reilly D; Flyer JN; Soll R; Mitra S
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013133. PubMed ID: 33448032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ibuprofen versus indomethacin in the treatment of patent ductus arteriosus in preterm infants].
    Gimeno Navarro A; Cano Sánchez A; Fernández Gilino C; Carrasco Moreno JI; Izquierdo Macián I; Gutiérrez Laso A; Morcillo Sopena F
    An Pediatr (Barc); 2005 Sep; 63(3):212-8. PubMed ID: 16219273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
    Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
    Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.